ProGnosis Biotech, headquartered in Greece, is a global diagnostics provider with 12 subsidiaries, including Italy, and distributors in over 90 countries. The company offers a wide range of ELISA and lateral flow test kits for the detection of mycotoxins, food allergens, antibiotic residues, GMOs, milk adulteration and histamine. It also provides hygiene monitoring solutions, including ATP and protein residue detection and clinical diagnostics. ProGnosis Biotech also designs and produces proprietary antibodies, hardware and software, including an Android mobile app for instant report sharing.
